Sol-Gel Technologies Ltd. Files Routine 6-K
Ticker: SLGL · Form: 6-K · Filed: May 20, 2024 · CIK: 1684693
| Field | Detail |
|---|---|
| Company | Sol-Gel Technologies Ltd. (SLGL) |
| Form Type | 6-K |
| Filed Date | May 20, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, 6-K, foreign-private-issuer
Related Tickers: SOLG
TL;DR
SOLG filed a 6-K, looks like standard reporting, no major news.
AI Summary
Sol-Gel Technologies Ltd. filed a Form 6-K on May 20, 2024, reporting as a foreign private issuer. The company, incorporated in Israel, is in the pharmaceutical preparations industry and has its principal executive offices in Ness Ziona. This filing is routine and does not contain specific financial updates or material events.
Why It Matters
This filing indicates Sol-Gel Technologies Ltd. is meeting its reporting obligations as a foreign private issuer, which is standard practice for companies listed on US exchanges.
Risk Assessment
Risk Level: low — This filing is a routine report and does not contain new material information that would typically impact risk.
Key Players & Entities
- Sol-Gel Technologies Ltd. (company) — Filer of the report
- 001-38367 (other) — SEC File Number
- 7 Golda Meir Street (other) — Business and Mail Address
- Ness Ziona (other) — City of Business and Mail Address
- Israel (other) — Country of Business and Mail Address
FAQ
What type of filing is this?
This is a Form 6-K, a Report of Foreign Private Issuer.
Who is the filer?
The filer is Sol-Gel Technologies Ltd.
When was this filing made?
The filing was made on May 20, 2024.
What is the company's primary business sector?
The company's Standard Industrial Classification is Pharmaceutical Preparations [2834].
Where are Sol-Gel Technologies Ltd.'s principal executive offices located?
The principal executive offices are located at 7 Golda Meir Street, Ness Ziona 7403650, Israel.
Filing Stats: 279 words · 1 min read · ~1 pages · Grade level 12.1 · Accepted 2024-05-20 07:15:09
Filing Documents
- zk2431489.htm (6-K) — 12KB
- exhibit_99-1.htm (EX-99.1) — 108KB
- image00001.jpg (GRAPHIC) — 17KB
- 0001178913-24-001778.txt ( ) — 144KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. SOL-GEL TECHNOLOGIES LTD. Date: May 20, 2024 By: /s/ Gilad Mamlok Gilad Mamlok Chief Financial Officer 3